Xylitol
Explore a selection of our essential drug information below, or:
Overview
- Description
- An ingredient added to dental products to remove bacteria.
- Description
- An ingredient added to dental products to remove bacteria.
- DrugBank ID
- DB11195
- Type
- Small Molecule
- Clinical Trials
- Phase 0
- 1
- Phase 1
- 39
- Phase 2
- 51
- Phase 3
- 81
- Phase 4
- 41
Identification
- Summary
Xylitol is an ingredient added to dental products to remove bacteria.
- Generic Name
- Xylitol
- DrugBank Accession Number
- DB11195
- Background
Xylitol is a naturally occurring five-carbon sugar alcohol found in most plant material, including many fruits and vegetables. Xylitol-rich plant materials include birch and beechwood 1. It is widely used as a sugar substitute and in "sugar-free" food products. The effects of xylitol on dental caries have been widely studied, and xylitol is added to some chewing gums and other oral care products to prevent tooth decay and dry mouth. Xylitol is a non-fermentable sugar alcohol by most plaque bacteria, indicating that it cannot be fermented into cariogenic acid end-products 4. It works by inhibiting the growth of the microorganisms present in plaque and saliva after it accummulates intracellularly into the microorganism 4. The recommended dose of xylitol for dental caries prevention is 6–10 g/day, and most adults can tolerate 40 g/day without adverse events 1.
- Type
- Small Molecule
- Groups
- Experimental, Investigational
- Structure
- Weight
- Average: 152.1458
Monoisotopic: 152.068473494 - Chemical Formula
- C5H12O5
- Synonyms
- D-Xylitol
- Xylitol
- External IDs
- E-967
- E967
- INS NO.967
- INS-967
Pharmacology
- Indication
Indicated for use as a sugar substitute, and oral hygiene active ingredient.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
There has been evidence of xylitol in dental hygiene in reducing dental caries disease and also reversing the process of early caries 1. Xylitol increases salivary flow and pH, reduces the levels of Streptococcus mutans in plaque and saliva and reduces the adhesion on the microorganism to the teeth surface 1. Streptococcus mutans is the main target plaque microorganism 2, but xylitol may potentially have inhibitory actions against several other bacterial species 1. It prevents a shift of the bacterial community towards a more cariogenic microflora in oral environment 4. Oral ingestion of xylitol causes a smaller rise in plasma glucose and insulin concentrations than does the ingestion of glucose in healthy men and diabetics 6.
- Mechanism of action
Xylitol is initially taken up by the microorganism and accumulates intracellularly. Accumulated xylitol is transported into an energy-consuming cycle, or the inducible fructose transport system. It is converted to non-metabolizable, toxic xylitol-5-phosphate via phosphoenolpyruvate: a constitutive fructose phosphotransferase system by S. mutans 1. This metabolic process of xylitol, without the gain of any energy molecules, results in the development of intracellular vacuoles and cell membrane degradation. S. mutans dephosphorylates xylitol-5-phosphate and expels it from the cell, in which requires energy consumption. This ultimately leading to starving of microorganism and growth inhibition 1. Long-term exposure to xylitol can cause microorganisms to develop resistance to xylitol. This clinically beneficial selection process creates xylitol-resistant mutans strains that are less virulent and less cariogenic than their parent strains 3. Xylitol also increases the concentrations of ammonia and amino acids in plaque, thereby neutralizing plaque acids 1. A study suggests that xylitol may also promote remineralization of deeper layers of demineralized enamel by facilitating Ca2+ and phosphate movement and accessibility 5.
Target Actions Organism UXylose isomerase Not Available Arthrobacter sp. (strain NRRL B3728) UXylose isomerase Not Available Streptomyces rubiginosus UXylose isomerase Not Available Streptomyces olivochromogenes UXylose isomerase Not Available Actinoplanes missouriensis (strain ATCC 14538 / DSM 43046 / CBS 188.64 / JCM 3121 / NCIMB 12654 / NBRC 102363 / 431) UHyaluronate lyase Not Available Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) - Absorption
Xylitol is absorbed in the small intestine via passive diffusion with a slow absorption rate 1.
- Volume of distribution
No pharmacokinetic data available.
- Protein binding
No pharmacokinetic data available.
- Metabolism
In mammals, xylitol is mainly metabolized in the liver where it is oxidized to D-xylulose by xylitol dehydrogenase and cofactor NAD. D-xyluose is further phosphorylated and metabolized by xylulose kinase to xylulose 5-phosphate (Xu5P), an intermediate of the nonoxidative branch of the pentose phosphate pathway 6. Xu5P is reported to activate nuclear transport and the DNA-binding activities of carbohydrate response element binding protein (ChREBP) via activation of activation of protein phosphatase 2A (PP2A) in vitro 6. Activation of ChREBP thereby upregulates the gene transcription of lipogenic enzymes in vitro, which may stimulate lipogenesis in the liver 6.
Hover over products below to view reaction partners
- Route of elimination
No pharmacokinetic data available.
- Half-life
No pharmacokinetic data available.
- Clearance
No pharmacokinetic data available.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Oral LD50 is 16500 mg/kg in rat MSDS. At high dosages, xylitol can cause diarrhea in children at 45 g/d and 100 g/d in adults 1.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Claon (toothpaste) Paste, dentifrice 0.07 g/100g Dental Mbg Inc (Korea Institute of Science Development) 2017-07-11 2018-07-11 US Hoo gargle (Jasmine Flavor)(Mouthwash) Liquid 1 g/100mL Dental MIKO CO LTD 2022-06-24 Not applicable US Hoo gargle (Mouthwash) Liquid 1 g/100mL Dental MIKO CO LTD 2021-04-20 Not applicable US Hoo gargle (Rooibos Tea Flavor)(Mouthwash) Liquid 1 g/100mL Dental MIKO CO LTD 2022-06-24 Not applicable US Medisupia Paste, dentifrice 0.07 g/100g Dental Mbg Inc (Korea Institute of Science Development) 2016-07-11 2016-07-11 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Adea Gargle Xylitol (5 g/100mg) + Sodium bicarbonate (36.2 g/100mg) Tablet, chewable Oral K2resource Co., Ltd. 2018-03-01 2018-04-01 US Adea Gargle Xylitol (5 g/100mg) + Sodium bicarbonate (36.2 g/100mg) Tablet, chewable Oral K2resource Co., Ltd. 2018-03-01 Not applicable US BOP whiteningtoothpaste Xylitol (3 g/100g) + Glycyrrhizinate dipotassium (0.3 g/100g) Gel Topical Shanghai Gemang Trading Co., Ltd. 2022-02-22 Not applicable US CHI. JOA (Anti-inflammatory effect, antibacterial effect, stomatitis improvement, plaque removal) Xylitol (1 g/100g) + Cinnamon (1 g/100g) + Levomenthol (1 g/100g) + Menthol (1 g/100g) + Myrrh (1 g/100g) + Pear (1 g/100g) + Peppermint (1 g/100g) + Sea salt (47 g/100g) + Silicon dioxide (1 g/100g) + Sorbitol (1 g/100g) Powder Topical BIOHERB Co., Ltd. 2023-07-11 2024-07-10 US Cream Xylitol (6 mg/30mg) + Glycerin (9 mg/30mg) + Silicic acid (4.5 mg/30mg) + Sorbitol (3 mg/30mg) Cream Dental Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Adea Gargle Xylitol (5 g/100mg) + Sodium bicarbonate (36.2 g/100mg) Tablet, chewable Oral K2resource Co., Ltd. 2018-03-01 2018-04-01 US Adea Gargle Xylitol (5 g/100mg) + Sodium bicarbonate (36.2 g/100mg) Tablet, chewable Oral K2resource Co., Ltd. 2018-03-01 Not applicable US BOP whiteningtoothpaste Xylitol (3 g/100g) + Glycyrrhizinate dipotassium (0.3 g/100g) Gel Topical Shanghai Gemang Trading Co., Ltd. 2022-02-22 Not applicable US CHI. JOA (Anti-inflammatory effect, antibacterial effect, stomatitis improvement, plaque removal) Xylitol (1 g/100g) + Cinnamon (1 g/100g) + Levomenthol (1 g/100g) + Menthol (1 g/100g) + Myrrh (1 g/100g) + Pear (1 g/100g) + Peppermint (1 g/100g) + Sea salt (47 g/100g) + Silicon dioxide (1 g/100g) + Sorbitol (1 g/100g) Powder Topical BIOHERB Co., Ltd. 2023-07-11 2024-07-10 US Claon (toothpaste) Xylitol (0.07 g/100g) Paste, dentifrice Dental Mbg Inc (Korea Institute of Science Development) 2017-07-11 2018-07-11 US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as sugar alcohols. These are hydrogenated forms of carbohydrate in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbohydrates and carbohydrate conjugates
- Direct Parent
- Sugar alcohols
- Alternative Parents
- Monosaccharides / Secondary alcohols / Polyols / Primary alcohols / Hydrocarbon derivatives
- Substituents
- Alcohol / Aliphatic acyclic compound / Hydrocarbon derivative / Monosaccharide / Polyol / Primary alcohol / Secondary alcohol / Sugar alcohol
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- pentitol (CHEBI:17151)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- VCQ006KQ1E
- CAS number
- 87-99-0
- InChI Key
- HEBKCHPVOIAQTA-SCDXWVJYSA-N
- InChI
- InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+
- IUPAC Name
- (2R,3r,4S)-pentane-1,2,3,4,5-pentol
- SMILES
- OC[C@H](O)[C@@H](O)[C@H](O)CO
References
- General References
- Nayak PA, Nayak UA, Khandelwal V: The effect of xylitol on dental caries and oral flora. Clin Cosmet Investig Dent. 2014 Nov 10;6:89-94. doi: 10.2147/CCIDE.S55761. eCollection 2014. [Article]
- Soderling E, Hirvonen A, Karjalainen S, Fontana M, Catt D, Seppa L: The effect of xylitol on the composition of the oral flora: a pilot study. Eur J Dent. 2011 Jan;5(1):24-31. [Article]
- Trahan L, Bourgeau G, Breton R: Emergence of multiple xylitol-resistant (fructose PTS-) mutants from human isolates of mutans streptococci during growth on dietary sugars in the presence of xylitol. J Dent Res. 1996 Nov;75(11):1892-900. doi: 10.1177/00220345960750111201. [Article]
- Trahan L: Xylitol: a review of its action on mutans streptococci and dental plaque--its clinical significance. Int Dent J. 1995 Feb;45(1 Suppl 1):77-92. [Article]
- Miake Y, Saeki Y, Takahashi M, Yanagisawa T: Remineralization effects of xylitol on demineralized enamel. J Electron Microsc (Tokyo). 2003;52(5):471-6. [Article]
- Amo K, Arai H, Uebanso T, Fukaya M, Koganei M, Sasaki H, Yamamoto H, Taketani Y, Takeda E: Effects of xylitol on metabolic parameters and visceral fat accumulation. J Clin Biochem Nutr. 2011 Jul;49(1):1-7. doi: 10.3164/jcbn.10-111. Epub 2011 Jun 17. [Article]
- External Links
- KEGG Drug
- D00061
- KEGG Compound
- C00379
- PubChem Substance
- 347911150
- ChemSpider
- 6646
- 11377
- ChEBI
- 17151
- ChEMBL
- CHEMBL96783
- ZINC
- ZINC000100018612
- PDBe Ligand
- XYL
- Wikipedia
- Xylitol
- PDB Entries
- 1fx5 / 1lte / 1njr / 1s5n / 1w3y / 1xig / 1xim / 1xin / 1xlc / 1xld … show 28 more
- MSDS
- Download (33.5 KB)
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Active Not Recruiting Not Available Asthma in Children / Exacerbation of asthma / Persistent Asthma 1 somestatus stop reason just information to hide Not Available Active Not Recruiting Not Available Chronic Obstructive Pulmonary Disease (COPD) 1 somestatus stop reason just information to hide Not Available Active Not Recruiting Supportive Care Cystic Fibrosis (CF) / Lung Disorder 1 somestatus stop reason just information to hide Not Available Completed Not Available Asthma 2 somestatus stop reason just information to hide Not Available Completed Not Available Chronic Obstructive Pulmonary Disease (COPD) 8 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Topical Powder Topical Cream Dental Paste Dental Tablet, chewable Oral Gel Dental Liquid Dental 1 g/100mL Inhalant Respiratory (inhalation) Paste, dentifrice Oral Aerosol Dental Paste, dentifrice Dental 0.07 g/100g Powder, dentifrice Dental 0.7 g/100g Paste, dentifrice Dental 0.7 g/100g Paste, dentifrice Dental Gum, chewing Dental 364 mg Gum, chewing Dental 827 mg / piece Paste, dentifrice Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 92-96 MSDS boiling point (°C) 215-217 MSDS - Predicted Properties
Property Value Source Water Solubility 664.0 mg/mL ALOGPS logP -2.5 ALOGPS logP -3.1 Chemaxon logS 0.64 ALOGPS pKa (Strongest Acidic) 12.76 Chemaxon pKa (Strongest Basic) -3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 5 Chemaxon Polar Surface Area 101.15 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 32.44 m3·mol-1 Chemaxon Polarizability 14.42 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.6885 Blood Brain Barrier - 0.6671 Caco-2 permeable - 0.8777 P-glycoprotein substrate Non-substrate 0.6813 P-glycoprotein inhibitor I Non-inhibitor 0.9518 P-glycoprotein inhibitor II Non-inhibitor 0.9247 Renal organic cation transporter Non-inhibitor 0.9142 CYP450 2C9 substrate Non-substrate 0.8802 CYP450 2D6 substrate Non-substrate 0.8706 CYP450 3A4 substrate Non-substrate 0.7419 CYP450 1A2 substrate Non-inhibitor 0.8471 CYP450 2C9 inhibitor Non-inhibitor 0.9326 CYP450 2D6 inhibitor Non-inhibitor 0.9343 CYP450 2C19 inhibitor Non-inhibitor 0.9169 CYP450 3A4 inhibitor Non-inhibitor 0.9519 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9681 Ames test Non AMES toxic 0.8869 Carcinogenicity Non-carcinogens 0.7794 Biodegradation Ready biodegradable 0.8084 Rat acute toxicity 0.9961 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9571 hERG inhibition (predictor II) Non-inhibitor 0.9235
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 130.6053069 predictedDarkChem Lite v0.1.0 [M-H]- 130.8490069 predictedDarkChem Lite v0.1.0 [M-H]- 132.13155 predictedDeepCCS 1.0 (2019) [M+H]+ 131.3458069 predictedDarkChem Lite v0.1.0 [M+H]+ 133.2577069 predictedDarkChem Lite v0.1.0 [M+H]+ 134.35063 predictedDeepCCS 1.0 (2019) [M+Na]+ 131.1450069 predictedDarkChem Lite v0.1.0 [M+Na]+ 140.26315 predictedDeepCCS 1.0 (2019)
Targets
- Kind
- Protein
- Organism
- Arthrobacter sp. (strain NRRL B3728)
- Pharmacological action
- Unknown
- General Function
- Not Available
- Specific Function
- magnesium ion binding
- Gene Name
- xylA
- Uniprot ID
- P12070
- Uniprot Name
- Xylose isomerase
- Molecular Weight
- 43291.15 Da
References
- Kind
- Protein
- Organism
- Streptomyces rubiginosus
- Pharmacological action
- Unknown
- General Function
- Involved in D-xylose catabolism.
- Specific Function
- identical protein binding
- Gene Name
- xylA
- Uniprot ID
- P24300
- Uniprot Name
- Xylose isomerase
- Molecular Weight
- 43226.915 Da
References
- Kind
- Protein
- Organism
- Streptomyces olivochromogenes
- Pharmacological action
- Unknown
- General Function
- Involved in D-xylose catabolism.
- Specific Function
- magnesium ion binding
- Gene Name
- xylA
- Uniprot ID
- P15587
- Uniprot Name
- Xylose isomerase
- Molecular Weight
- 42922.7 Da
References
- Kind
- Protein
- Organism
- Actinoplanes missouriensis (strain ATCC 14538 / DSM 43046 / CBS 188.64 / JCM 3121 / NCIMB 12654 / NBRC 102363 / 431)
- Pharmacological action
- Unknown
- General Function
- Not Available
- Specific Function
- magnesium ion binding
- Gene Name
- xylA
- Uniprot ID
- P12851
- Uniprot Name
- Xylose isomerase
- Molecular Weight
- 43498.425 Da
References
- Kind
- Protein
- Organism
- Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
- Pharmacological action
- Unknown
- General Function
- Not Available
- Specific Function
- carbohydrate binding
- Gene Name
- Not Available
- Uniprot ID
- Q54873
- Uniprot Name
- Hyaluronate lyase
- Molecular Weight
- 120770.645 Da
References
Drug created at December 03, 2015 16:51 / Updated at September 28, 2021 21:54